Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy

Area of Science:

• Immunology
• Neurology
• Clinical Medicine

Background:

• Chronic inflammatory demyelinating polyneuropathy (CIDP) is associated with defective Concanavalin A (ConA)-induced suppressor cell function.
• The role of this defect in CIDP disease activity and its importance in recovery remain to be fully elucidated.

Purpose of the Study:

• To investigate the modifications of ConA-induced suppressor cell function following treatment in patients with CIDP.
• To assess the correlation between changes in suppressor cell function and clinical improvement.

Main Methods:

• Studied 20 patients diagnosed with CIDP.
• Monitored ConA-induced suppressor cell function before and after treatment with prednisone and plasma exchange.
• Assessed clinical improvement in parallel with immunological marker changes.

Main Results:

• Treatment with prednisone and plasma exchange led to a significant increase in ConA-induced suppressor cell function, moving towards normal levels.
• The improvement in suppressor cell function was concurrent with observed clinical improvement in the patients.
• These findings suggest a potential mechanism involving the induction of suppression through cytokine network modulation.

Conclusions:

• Prednisone and plasma exchange may restore ConA-induced suppressor cell function in CIDP patients.
• The restoration of suppressor cell function appears to be linked to clinical recovery in CIDP.
• Modulation of the cytokine network or other humoral mediators could underlie the therapeutic efficacy of these treatments in CIDP.